Valid: July 7, 2023 through July 6, 2024 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. Activity Description Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing, autoimmune disease of the central nervous system that is characterized by inflammation …
Category Archives: ACPE
ForuMS: Highlights in MS Care from 2022
Released On: May 15, 2023 Expires On: May 15, 2024 Provider Statement This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. Support Statement This activity is supported by independent educational grants from Novartis Pharmaceuticals Corporation Credit Available Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™ Nurses — 1.25 …
PATIENTGPS™: Clinical Paths in Modern Treatment of Multiple Sclerosis – Philadelphia, PA
Tuesday, August 22, 2023 6:00 pm – 8:00 pm Dinner and Presentation MOSHULU 401 S Columbus Blvd Philadelphia, PA 19106 Expert Faculty James Bowen, MD Multiple Sclerosis Center Swedish Neuroscience Institute Seattle, WA 6:00-6:30 pm Registration 6:30 pm Faculty introduction and pretest Dinner served Case studies in individualized treatment decisions and symptom management Case study 1: …
PatientGPS™: Clinical Paths in ModernTreatment of Multiple Sclerosis
Released: April 5, 2023 Expires: April 5, 2024 Program Description An interactive and patient-centric CE learning experience, including discussion of patient cases depicting clinical challenges associated with the personalized treatment of multiple sclerosis (MS). Intended Audience Neurologists, advanced practice clinicians, nurses, pharmacists, and other clinicians who are part of the team that manages patients with …
Continue reading “PatientGPS™: Clinical Paths in ModernTreatment of Multiple Sclerosis”
Stop the Press: Is this MS? Primary Care’s Role in Recognizing and Coordinating Care for Patients with Multiple Sclerosis
Overview Release date: March 2, 2023Expiration date: March 2, 2024The estimated time to complete the activity is 60 minutes. Provider Statement This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. Support Statement This activity is supported by independent educational grants from Genentech, Jazz Pharmaceuticals, and Novartis Pharmaceuticals …
Contemporary Considerations in Multiple Sclerosis Treatment: A Post-Pandemic Educational Curriculum MedPoints™ in Multiple Sclerosis
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBiogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, PAs, and patient advocates in the care of people living with multiple sclerosis (MS). Faculty Robert …
Building Clinical Confidence: Evidence-based Care for People Living with MS
This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC)and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. Target Audience Neurologists, primary care physicians, nurse practitioners, nurses, physician associates (PAs), rehabilitation specialists, mental health specialists, radiologists, and other clinicians who are part …
Continue reading “Building Clinical Confidence: Evidence-based Care for People Living with MS”
Contemporary Considerations in Multiple Sclerosis Treatment:
A Post-Pandemic Educational Curriculum
Release Date: January 10, 2023 Valid for Credit through: January 10, 2024 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants from Biogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, physician assistants, and …
Building Clinical Confidence: Evidence-based Care for People Living with MS
Released On: December 5, 2022 Expires On: December 5, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. This activity can take up to 75 minutes to complete. Target Audience Neurologists, primary …
Continue reading “Building Clinical Confidence: Evidence-based Care for People Living with MS”
Collaborating Across the Continuum™: Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy
Release Date: November 30, 2022 Expiration Date: November 30, 2023 Faculty: Stephen Krieger, MD, FAAN Jacci Bainbridge, PharmD, FCCP Denise Bruen, ANP-BC, MSN, MSCN Activity Overview Following the success of anti-CD20 antibodies in the treatment of multiple sclerosis (MS), there has been a shift in understanding of its pathophysiology. B cells have been identified as …